RJ

Ravindra Janrao Bonde

Active Director Director DIN 09407887
DIN 09407887 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravindra Janrao Bonde

Data last updated:

Ravindra Janrao Bonde is a Director at Dreamcure Pharmaceutical Private Limited (since 2021). The company operates in Pharma.

DIN 09407887
Primary Designation Director
Industry Pharma
First Appointment 22 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Nov 20212021Active

Directorship timeline

Open interactive timeline →
Dreamcure Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ravindra Janrao Bonde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindra Janrao Bonde

Ravindra Janrao Bonde currently holds 1 directorship: Dreamcure Pharmaceutical Private Limited (Director, since 22 Nov 2021).

Ravindra Janrao Bonde was first appointed on 22 Nov 2021 as Director at Dreamcure Pharmaceutical Private Limited.

The current boards of Ravindra Janrao Bonde's companies include Amit Balki (Dreamcure Pharmaceutical Private Limited), Chhatrapati Pandurang Manapure (Dreamcure Pharmaceutical Private Limited), Swapnil Chandurkar (Dreamcure Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available